Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: The answer from PTSC to the USPTO contingency is .....
Read Virt's theory--and consider that there may be a cross license agreement. Either one of those is possible and would be GOOD for PTSC and TPL. GL, ads

May 15, 2008 08:21AM
1
May 15, 2008 08:26AM
Share
New Message
Please login to post a reply